FDA Warning Letter — SemaBio

Case 715866 — FEI 3039694268

The FDA took a Warning Letter action against SemaBio on Sep 9, 2025 (Bellevue, WA). The action was issued by CDER and concerns drugs products.

Action details

Facility
SemaBio
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Bellevue, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.